Interleukin-1β induces cyclooxygenase-2 and prostaglandin E2 synthesis in human neuroblastoma cells:: Involvement of p38 mitogen-activated protein kinase and nuclear factor-κB

被引:102
作者
Fiebich, BL [1 ]
Mueksch, B [1 ]
Boehringer, M [1 ]
Hüll, M [1 ]
机构
[1] Univ Freiburg, Sch Med, Dept Psychiat, D-79104 Freiburg, Germany
关键词
cyclooxygenase; SK-N-SH neuroblastoma cells; reactive oxygen intermediates; nonsteroidal antiinflammatory drugs; Alzheimer's disease; prostaglandin E-2;
D O I
10.1046/j.1471-4159.2000.0752020.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prostaglandins (PGs), which are generated by the enzymatic activity of cyclooxygenase (COX)-1 and -2, modulate several functions in the CNS such as the generation of fever, the sleep/wake cycle, and the perception of pain. Moreover, the neuronal induction of COX-2 has been linked to neuroinflammatory aspects of Alzheimer's disease (AD). The regulation of COX expression in neuronal cells is only partly understood and has been mainly linked to synaptic activity. In pathophysiological situations, however, cytokines may be potent stimulators of neuronal COX expression. Here we show that interleukin (IL)-1 beta induces COX-2 mRNA and protein synthesis and the release of PGE(2) in the human neuroblastoma cell line SK-N-SH. We further demonstrate that both a free radical scavenger and an inhibitor of p38 mitogen-activated protein kinase (MAPK) reduce IL-1 beta-induced synthesis of COX-2. IL-1 beta induces p38 MAPK phosphorylation and activation of the nuclear factor-kappa B independently from each other. Our data suggest that IL-1 beta-induced COX-2 expression in SK-N-SH cells is regulated by different mechanisms, presumably involving mRNA transcription and mRNA stability. The ability of p38 MAPK to augment COX-2 expression in human neuroblastoma cells, as shown here, suggests that p38 MAPK may be involved in neuronal expression of COX-2 in AD.
引用
收藏
页码:2020 / 2028
页数:9
相关论文
共 57 条
  • [31] Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-γ in Alzheimer's disease brains
    Kitamura, Y
    Shimohama, S
    Koike, H
    Kakimura, J
    Matsuoka, Y
    Nomura, Y
    Gebicke-Haerter, PJ
    Taniguchi, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 254 (03) : 582 - 586
  • [32] KUJUBU DA, 1991, J BIOL CHEM, V266, P12866
  • [33] CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4
    LAEMMLI, UK
    [J]. NATURE, 1970, 227 (5259) : 680 - +
  • [34] Lieb K, 1996, J NEUROCHEM, V66, P1496
  • [35] Lukiw WJ, 1997, J NEUROSCI RES, V50, P937, DOI 10.1002/(SICI)1097-4547(19971215)50:6<937::AID-JNR4>3.0.CO
  • [36] 2-E
  • [37] Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A(2)
    Miettinen, S
    Fusco, FR
    Yrjanheikki, J
    Keinanen, R
    Hirovonen, T
    Roivainen, R
    Narhi, M
    Hokfelt, T
    Koistinaho, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) : 6500 - 6505
  • [38] Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates
    Muller, JM
    Rupec, RA
    Baeuerle, PA
    [J]. METHODS, 1997, 11 (03) : 301 - 312
  • [39] Evidence for involvement of NF-kappa B in the transcriptional control of COX-2 gene expression by IL-1 beta
    Newton, R
    Kuitert, LME
    Bergmann, M
    Adcock, IM
    Barnes, PJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 237 (01) : 28 - 32
  • [40] OBanion MK, 1996, J NEUROCHEM, V66, P2532